Drug intelligence / Profile preview

3-(butylsulfonyl)propanoic acid

Development stage: Unknown
Modality: Small Molecules

Overview

3-(Butylsulfonyl)propanoic acid is a small molecule organic compound belonging to the class of sulfones, characterized by a propanoic acid backbone substituted with a butylsulfonyl group. Its molecular formula is C7H14O4S and it has a molecular weight of approximately 194.25 g/mol. The compound is listed as experimental in drug databases and does not have any approved medical indications or known clinical trial activity as of June 2025. There are no detailed reports on its mechanism of action, pharmacological effects, or therapeutic applications in humans[7][10].

Other names: 3-(Butylsulphonyl)-propanoic acid3-(butane-1-sulfonyl)propanoic acid

Beyond the preview

Go deeper on 3-(butylsulfonyl)propanoic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3-(butylsulfonyl)propanoic acid.

Explore the full profile